EMA Lays Out Plans For Routine Use Of Real-World Evidence

EU Draft Artificial Intelligence Guideline Slated For November 2022

 
• By Vibha Sharma
  
Futuristic programming code and big data connections and network patterns. 3D illustration.
Regulators will increasingly use insights derived from big data to assess the benefit-risk of medicines • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials